Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valder R Arruda

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Human Molecular Genetics|October 10, 2019
Gene therapy matures to medicinesBeverly L Davidson, Valder R Arruda
Frontiers in Immunology|May 20, 2020
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia ABenjamin J Samelson-Jones, Valder R Arruda
Expert Opinion on Orphan Drugs|February 23, 2016
Obstacles and future of gene therapy for hemophiliaValder R Arruda, Ben J Samelson-Jones
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Protein-Engineered Coagulation Factors for Hemophilia Gene TherapyBenjamin J Samelson-Jones, Valder R Arruda
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
Biodistribution and shedding of AAV vectorsCaroline Le Guiner, Phillipe Moullier, Valder R Arruda
Blood|July 6, 2022
Immune complications and their management in inherited and acquired bleeding disordersValder R Arruda, David Lillicrap, Roland W Herzog
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2009
Strategies to modulate immune responses: a new frontier for gene therapyValder R Arruda, Patricia Favaro, Jonathan D Finn
Blood|February 1, 2023
Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivoLacramioara Ivanciu, Valder R Arruda, Rodney M Camire
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2020
Inhibitors-Recent insightsKathleen P Pratt, Valder R Arruda, Sébastien Lacroix-Desmazes
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 24, 2019
Gene therapy for hemophilia: Progress to date and challenges moving forwardKandace L Gollomp, Bhavya S Doshi, Valder R Arruda
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Human Molecular Genetics|October 10, 2019
Gene therapy matures to medicinesBeverly L Davidson, Valder R Arruda
Frontiers in Immunology|May 20, 2020
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia ABenjamin J Samelson-Jones, Valder R Arruda
Expert Opinion on Orphan Drugs|February 23, 2016
Obstacles and future of gene therapy for hemophiliaValder R Arruda, Ben J Samelson-Jones
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Protein-Engineered Coagulation Factors for Hemophilia Gene TherapyBenjamin J Samelson-Jones, Valder R Arruda
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
Biodistribution and shedding of AAV vectorsCaroline Le Guiner, Phillipe Moullier, Valder R Arruda
Blood|July 6, 2022
Immune complications and their management in inherited and acquired bleeding disordersValder R Arruda, David Lillicrap, Roland W Herzog
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2009
Strategies to modulate immune responses: a new frontier for gene therapyValder R Arruda, Patricia Favaro, Jonathan D Finn
Blood|February 1, 2023
Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivoLacramioara Ivanciu, Valder R Arruda, Rodney M Camire
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2020
Inhibitors-Recent insightsKathleen P Pratt, Valder R Arruda, Sébastien Lacroix-Desmazes
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 24, 2019
Gene therapy for hemophilia: Progress to date and challenges moving forwardKandace L Gollomp, Bhavya S Doshi, Valder R Arruda
Pageof 9